HFD-fed mice given Gly-MCA had improved insulin sensitivity and resolution of fatty liver, and thus the question arises whether these improved metabolic endpoints are the result of lower obesity. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.